ANATOMIC STAGE IV BREAST CANCER AJCC V8
Clinical trials for ANATOMIC STAGE IV BREAST CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new ANATOMIC STAGE IV BREAST CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for ANATOMIC STAGE IV BREAST CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart drug may reboot immunotherapy for tough breast cancer
Disease control Not yet recruitingThis study tests whether adding a common heart medication (propranolol) to an immunotherapy drug (pembrolizumab) can help shrink tumors in people with advanced triple-negative breast cancer that no longer responds to standard treatment. About 37 adults whose cancer has spread or …
Matched conditions: ANATOMIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 17, 2026 00:53 UTC
-
Radiation-Zapping drug shows promise for tough breast cancer
Disease control Not yet recruitingThis study tests a drug called 177Lu-DOTATATE in 10 people with stage IV or recurrent breast cancer. The drug targets cancer cells that have a specific marker (SSTR2) and delivers radiation to kill them. The goal is to see if it can shrink tumors and control the disease. Particip…
Matched conditions: ANATOMIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New radiation drug targets bone tumors with less marrow harm
Disease control Not yet recruitingThis early-stage trial tests a new version of a radiation drug (Sn-117m-DTPA) designed to target tumors that have spread to the bones from prostate, breast, or lung cancer. The drug delivers low-level radiation directly to bone tumors while being gentler on the bone marrow. The s…
Matched conditions: ANATOMIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 06, 2026 16:02 UTC
-
Smart report aims to match breast cancer patients with best drugs
Knowledge-focused Not yet recruitingThis early-stage study tests whether a special report, created from a patient's tumor tissue, can help doctors choose better treatments for advanced hormone receptor-positive breast cancer that has spread or cannot be removed by surgery. The report lists which drugs might work an…
Matched conditions: ANATOMIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated May 17, 2026 00:52 UTC